Cite
HARVARD Citation
Mazzoleni, S. et al. (2020). Temferon an ex-vivo genetically modified cell therapy aiming to fill the gaps for solid tumor immunotherapy. Cell & gene therapy insights. 6 (9), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mazzoleni, S. et al. (2020). Temferon an ex-vivo genetically modified cell therapy aiming to fill the gaps for solid tumor immunotherapy. Cell & gene therapy insights. 6 (9), p. . [Online].